Cytomx Therapeutics, Inc.
CTMX
Revenue
18.66M
▼-32.26M▼-63.36%
3 Months ChangeAssets
175.06M
▲76.56M▲77.73%
3 Months ChangeLiabilities
55.15M
▼-18.30M▼-24.92%
3 Months ChangeFree Cash Flow
-21.16M
▲5.00M▲19.11%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 8-K
ID: 0000950170-24-093936
2024-08-08
Form 10-Q
ID: 0000950170-24-093865
2024-06-17
Form 8-K
ID: 0001193125-24-162652
2024-05-17
Form 8-K
ID: 0001193125-24-141699
2024-05-08
Form 8-K
ID: 0001193125-24-134284
2024-05-08
Form 8-K
ID: 0000950170-24-055598
2024-05-08
Form 10-Q
ID: 0000950170-24-055588
2024-03-22
Form 8-K
ID: 0001193125-24-075211
2024-03-11
Form 8-K
ID: 0000950170-24-029207
2023-11-07
Form 8-K
ID: 0000950170-23-060221